Pilot Study of Prism EFP NeuroFeedback in Adult ADHD

 

/ Adler, L. A., Anbarasan, D., Leon, T., Sardoff, T., Descorbeth, O., Cho, D., Stern, Y., Kraft, O., Hendler, T., & Marmar, C. R. Journal of Attention Disorders, 28(5), 905-912.

​

Demonstrating the potential of amygdala-EFP neurofeedback for improving ADHD symptoms.

Emotional dysregulation is a common symptom of ADHD, which often comes with an overactive amydala. Therefore, learning to down-regulate brain activity in the amygdala may be useful in treatment of ADHD. This pilot study tested the feasibility of amygdala-EFP neurofeedback Prism treatment in 9 participants with ADHD, lasting 5 to 8 weeks. At the end of the treatment, a two-thirds reduction was seen in total DSM ADHD symptom scores, together with improvement in all other clinical measures. These preliminary results indicate the potential of Prism neurofeedback treatment to be tested as a treatment option for ADHD in a wider cohort.

​

To read the full article on Psychiatry and Clinical Neurosciences - https://journals.sagepub.com/doi/10.1177/10870547231215283